03/22/2024 8:21 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 6:50 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/20/2024 3:12 PM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/15/2024 3:11 PM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/12/2024 3:19 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:11 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:14 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/11/2024 7:59 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:03 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:34 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
02/29/2024 5:35 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:49 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:38 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 5:09 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T | |
02/13/2024 4:48 PM | Gilead Sciences (Reporting) Kyverna Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 7:37 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 7:39 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-C | |
02/09/2024 5:21 PM | Capital World Investors (Filed by) Gilead Sciences (Subject)
| Form SC 13G/A | |
02/07/2024 4:35 PM | Gilead Sciences (Reporting) Kyverna Therapeutics, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/06/2024 5:01 PM | Gilead Sciences (Issuer) LOVE TED W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:20 PM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 1:42 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:34 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:19 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:11 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 12:40 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:58 PM | Arcus Biosciences, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC 13D/A | |
01/31/2024 4:00 PM | Arcus Biosciences, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Gilead Sciences (Subject)
| Form SC 13G/A | |
01/17/2024 5:01 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 3:32 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:35 PM | Gilead Sciences (Subject) Mercier Johanna (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023 3:36 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:06 PM | Arcellx, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC 13G/A | |
12/28/2023 4:09 PM | Arcellx, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/22/2023 3:07 PM | Gilead Sciences (Reporting) HOOKIPA Pharma Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/11/2023 6:00 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:04 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:08 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:10 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:15 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Warning: this could blow your mind (Ad) Buckle up…
‘Cause this might shatter everything you’ve heard about “income trading”.
In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it:
The Perfect Income Trade
You see, most of the income techniques out there target a couple of percent.
Maybe 5 - 10 percent if you’re lucky.
But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return.
And here’s the best news of all:
This trade can target an opportunity like that every week. Every single week.
Meaning an investor has the chance to “stack up” these more aggressive income trades over and over.
If that sounds interesting… Watch the presentation here |
11/13/2023 5:21 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 4:18 PM | Gilead Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023 4:56 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2023 6:15 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer) Gilead Sciences (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/25/2023 4:18 PM | ASSEMBLY BIOSCIENCES, INC. (Subject) Gilead Sciences (Filed by)
| Form SC 13D | |
10/19/2023 2:33 PM | Gilead Sciences (Filed by) Ikena Oncology, Inc. (Subject)
| Form SC 13G | |
10/18/2023 3:31 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:18 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2023 7:09 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 8:00 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 5:50 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:21 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 7:37 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 7:40 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 7:44 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 7:11 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 7:19 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 3:09 PM | Gilead Sciences (Filer)
| Form 424B5 | |
09/07/2023 4:28 PM | Gilead Sciences (Subject)
| Form FWP | |
09/07/2023 7:29 AM | Gilead Sciences (Filer)
| Form 424B5 | |
08/16/2023 4:19 PM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/04/2023 4:23 PM | Gilead Sciences (Filer)
| Form S-3ASR | |
07/25/2023 5:15 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/21/2023 4:30 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 8:38 AM | Arcus Biosciences, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC 13D/A | |
06/30/2023 2:54 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 2:12 PM | Arcus Biosciences, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 4:17 PM | Allovir, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 4:48 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 4:29 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023 3:45 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:50 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2023 10:15 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 6:10 PM | BARTON JACQUELINE K (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:15 PM | Gilead Sciences (Issuer) Kramer Kelly A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 5:02 PM | Gilead Sciences (Issuer) Horning Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 5:13 PM | Bluestone Jeffrey (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 4:47 PM | Gilead Sciences (Issuer) WELTERS ANTHONY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 4:51 PM | Gilead Sciences (Issuer) MANWANI HARISH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 4:53 PM | Gilead Sciences (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 4:57 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2023 6:12 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/06/2023 2:29 PM | Gilead Sciences (Subject) Intercommunity Peace & Justice Center (Filed by)
| Form PX14A6G | |
03/31/2023 7:29 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2023 10:25 AM | Chevedden John (Filed by) Gilead Sciences (Subject)
| Form PX14A6G | |